|Articles|April 1, 2016
- Pharmaceutical Executive-04-01-2016
- Volume 36
- Issue 4
Pharmaceutical Executive, April 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Closing the Gaps in Drug Chain of Custodyabout 10 years ago
Data Unleashed: Cooperation Among Competitorsabout 10 years ago
Raising the Stakes On Value-Based Pricingabout 10 years ago
The Diversity Dearth in Pharmaover 10 years ago
Information in Action: A Conversation with Barbara Lopez Kunzover 10 years ago
R&D Model Mixes Compassion, Calculationover 10 years ago
Pressure Builds to Revamp Off-Label Marketing Rulesover 10 years ago
Drug Compounding: A Cause and Cure for High Drug Prices?over 10 years ago
The Odd Coupleover 10 years ago
Country Report: EgyptAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
U.S. House Committee Investigating Drugmakers Involved in China Drug Trials: Report
2
Preparing for the July 31 Pharma Tariff Deadline
3
AlzeCure Pharma Enters $2.2 Billion Licensing and Collaboration Agreement with QuantumCell ApS
4
Uncertainty Surrounding Pharma Tariff Deadlines
5